EUVIMEDEUVIMED entdecken
Crossref

Diagnostic and prognostic value of MRI-based Node-RADS for the assessment of regional lymph node metastasis in renal cell carcinoma

Xu Bai, Cheng Peng, Baichuan Liu, Shaopeng Zhou, Haili Liu, Yijian Chen, Huiping Guo, Yuwei Hao, Xin Liu, Jian Zhao, Xiaohui Ding, Lin Li und 4 weitere

Diagnostic and Interventional Imaging · 2025

DOI: 10.1016/j.diii.2024.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic and Interventional Imaging, 2025. Verfasst von Xu Bai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, First Medical Center, Chinese PLA General Hospital, Haidian District, Beijing 100853, China; Department of Radiology, Fifth …. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Lymphatic Metastasis, Magnetic Resonance Imaging. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The purpose of this study was to assess the capabilities of MRI-based Node Reporting and Data System (Node-RADS) in diagnosing regional lymph node metastasis (RLNM) and to estimate its prognostic significance in patients with renal cell carcinomas (RCCs). MATERIALS AND METHODS: Patients with RCC who underwent nephrectomy and regional lymph node dissection between January 2010 and August 2023 were retrospectively included. Two senior radiologists scored lymph nodes in consensus using MRI-based Node-RADS. The performance of MRI-based Node-RADS for the diagnosis of RLNM was estimated using area under receiver operating characteristic (AUC) curves and compared against size criteria. Three additional readers scored all lesions to assess interobserver agreement. Progression-free survival and overall survival were estimated and compared between patients with low (1-3) and high (4-5) scores. RESULTS: Overall, 216 patients with RCC were enrolled, including 58 with RLNM. There were 157 men and 59 women with a median age of 54 years (range: 8-83 years). Node-RADS showed larger AUC (0.93 [95 % confidence interval (CI): 0.87-0.97]) and higher specificity (96.8 % [95 % CI: 92.8-99.0]) compared to size criteria (0.88 [95 % CI: 0.83-0.94] and 87.3 % [95 % CI: 81.1-92.1], respectively) for the diagnosis of RLNM (P = 0.039 and P < 0.001, respectively). Substantial interobserver agreement in Node-RADS scoring was obtained between the three readers (weighted κ, 0.75 [95 % CI: 0.69-0.80]). During a median follow-up of 56 months, patients with high Node-RADS score experienced poorer progression-free survival (P < 0.001) and overall survival (P < 0.001) than those with low Node-RADS score. At multivariable Cox regression analysis, Node-RADS was an independent variable associated with RCC prognosis after adjustment for confounders. CONCLUSIONS: The MRI-based Node-RADS demonstrates notable performance in detecting RLNM and showed potential prognostic significance for RCCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsLymphatic MetastasisMagnetic Resonance ImagingHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAged, 80 and overAdultPrognosisAdolescentYoung AdultChildNephrectomyLymph NodesLymph Node Excision

Stichwörter der Autor:innen

Lymphatic metastasisMagnetic resonance imagingNode Reporting and Data System (Node-RADS)PrognosisRenal cell carcinoma

Autor:innen und Institutionen

  • Department of Radiology, First Medical Center, Chinese PLA General Hospital, Haidian District, Beijing 100853, China; Department of Radiology, Fifth Medical Center, Chinese PLA General Hospital, Beijing 100039, China.
  • Department of Urology, First Medical Center, Chinese PLA General Hospital, Haidian District, Beijing 100853, China.
  • Department of Radiology, First Medical Center, Chinese PLA General Hospital, Haidian District, Beijing 100853, China.
  • Department of Radiology, Fourth Medical Center, Chinese PLA General Hospital, Haidian District, Beijing 100048, China.
  • Department of Radiology, Chinese PLA 920 Hospital, Xishan District, Kunming 650118, China.
  • Department of Radiology, Armed Police Force Hospital of Sichuan, Leshan, Sichuan 614000, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Bai, X., Peng, C., Liu, B., Zhou, S., Liu, H., Chen, Y., Guo, H., Hao, Y., Liu, X., Zhao, J., Ding, X., Li, L., Zhang, X., Ye, H., Ma, X., & Wang, H. (2025). Diagnostic and prognostic value of MRI-based Node-RADS for the assessment of regional lymph node metastasis in renal cell carcinoma. Diagnostic and Interventional Imaging. https://doi.org/10.1016/j.diii.2024.10.005

Vancouver

Bai X, Peng C, Liu B, Zhou S, Liu H, Chen Y, et al. Diagnostic and prognostic value of MRI-based Node-RADS for the assessment of regional lymph node metastasis in renal cell carcinoma. Diagnostic and Interventional Imaging. 2025. doi:10.1016/j.diii.2024.10.005

BibTeX
@article{Bai2025,
  author = {Bai, Xu and Peng, Cheng and Liu, Baichuan and Zhou, Shaopeng and Liu, Haili and Chen, Yijian and Guo, Huiping and Hao, Yuwei and Liu, Xin and Zhao, Jian and Ding, Xiaohui and Li, Lin and Zhang, Xu and Ye, Huiyi and Ma, Xin and Wang, Haiyi},
  title = {Diagnostic and prognostic value of MRI-based Node-RADS for the assessment of regional lymph node metastasis in renal cell carcinoma},
  journal = {Diagnostic and Interventional Imaging},
  year = {2025},
  doi = {10.1016/j.diii.2024.10.005}
}
Kostenlos starten →